Middle Cerebral Artery Doppler( MCA-PSV) & Perinatal Outcome

NCT07135635 · tracked via the Priya Life Science Egypt tracker

Sponsor

Sohag University

Phase

Observational

Started

2025-05-01

Last updated

2025-08-22

Condition(s) studied

Anemia During PregnancyAnemia Complicating PregnancyAnemia

Investigational drug(s) / intervention(s)

Middle Cerebral Artery doppler

Middle Cerebral Artery doppler: All cases of pregnant women diagnosed with anemia at 3rd trimester will have baseline assessment of history, clinical examination, HB level, obstetric ultrasonography done then they will have Middle Cerebral Artery Doppler done to assess correlation between MCA Doppler indices \& neonatal outcomes. Then appropriate treatment of anemia will be taken.

Study summary

can we predict neonatal outcome by the results of 3rd trimester MCA Doppler Indices In pregnant women with anemia?? --- the aim of this study is to evaluate values of MCA Doppler indices in determining fetal outcome in pregnant women with anemia.

Eligibility

Sex

FEMALE

Min age

—

Max age

—

Healthy volunteers

Accepted

Inclusion Criteria: \- (1) Pregnant women diagnosed with anemia at 3rd trimester with hemoglobin level ≤ 11 g/dl. (2) Singleton pregnancy. Exclusion Criteria: 1. Multifetal pregnancy. 2. Fetal Anomalies. 3. Any other maternal systemic diseases other than anemia as DM, Preeclampsia, Autoimmune disease.

Primary outcome measure(s)

Third Trimester Middle Cerebral artery Doppler ( MCA -PSV). — 1 year
Assess correlation between MCA Doppler indices and neonatal Hemoglobin level — 1 year

Trial sites (1)

Facility	City	Region	Status
Faculty of Medicine- Sohag University	Sohag	Egypt

More Sohag University trials in Egypt

Peripheral Artery Disease in Regular Hemodialysis Patients Active, not recruiting

the Role of MRI in Evaluation of Low Back Pain Recruiting

Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes Starting soon

Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety Recruiting

Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura Recruiting

Other trials for the same condition

The Influence of Anemia on HbA1c Readings in Non-Diabetic Patients Starting soon

Anemia-Related Outcomes in Patients With CKD Treated With Dapagliflozin Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07135635 on ClinicalTrials.gov ↗ ← All trials in Egypt